INHIBITORS OF THE MENIN-MLL INTERACTION

The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.

Saved in:
Bibliographic Details
Main Authors DAVID A CLAREMON, SURESH B SINGH, SALVACION CACATIAN, ANDREW MARCUS, ANGEL MORALES-RAMOS, LINGHANG ZHUANG, STEPHEN D LOTESTA, TRAVIS L HOUSTON, YI FAN, CHENGGUO DONG, LANQI JIA, YAJUN ZHENG, SHANKAR VENKATRAMAN, JING YUAN, STEPHAN D PARENT, LAWRENCE WAYNE DILLARD
Format Patent
LanguageEnglish
Published 26.04.2023
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
Bibliography:Application Number: ZA20190000150